In contrast, NKX6-3 is highly expressed in TCF3-subtype BCP-ALL and GC-B-cell-derived diffuse large B-cell lymphoma subsets, contrastingly indicating oncogene activity in developing B-cells [10]. Here, NKX6-3 is linked to acute lymphoblastic leukemia.